Earnings History Data for Oric Pharmaceuticals, Inc. (ORIC) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Oric Pharmaceuticals, Inc.

ORIC Pharmaceuticals Inc. is a clinical stage oncology company. It is focused on developing treatments which address mechanisms of therapeutic resistance. The company's product candidate consists of ORIC-101 and ORIC-533 which are in clinical stage. ORIC Pharmaceuticals Inc. is based in San Francisco, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
06-05-2024	AH		ORIC	Oric Pharmaceuticals	642.00	-0.37	-0.44	0.00	ORIC Pharmaceuticals GAAP EPS of -$0.37 beats by $0.07 [5/6/2024 5:32 PM]	9.64	0.27 (2.88%)	9.37	0.0 (0.00%)	4.90 - 16.65	302,012	480,000	4,409
ORIC Pharmaceuticals GAAP EPS of -$0.37 beats by $0.07 [5/6/2024 5:32 PM]
11-03-2024	AH		ORIC	Oric Pharmaceuticals	1,072	-0.49	-0.49	0.00	ORIC Pharmaceuticals GAAP EPS of -$0.49 [3/11/2024 5:01 PM]	14.30	-0.69 (-4.60%)	14.99	0.0 (0.00%)	4.12 - 16.65	768,758	800,000	6,904
ORIC Pharmaceuticals GAAP EPS of -$0.49 [3/11/2024 5:01 PM] ORIC Pharmaceuticals files for automatic mixed securities shelf [3/11/2024 5:34 PM]
10-08-2023	PM		ORIC	Oric Pharmaceuticals, Inc.	342.71	-0.50	-0.58	-0.51	ORIC Pharmaceuticals GAAP EPS of -$0.50 beats by $0.08 [8/11/2023 4:09 AM]	8.77	0.84 (10.59%)	8.26	0.33 (4.16%)	2.36 - 9.09	731,034	180,000	7,427
ORIC Pharmaceuticals GAAP EPS of -$0.50 beats by $0.08 [8/11/2023 4:09 AM]
16-03-2023	AH	4:05 PM ET (Mar 16)	ORIC	Oric Pharmaceuticals	184.00	-0.52	-0.56	0.00	ORIC Pharmaceuticals GAAP EPS of -$0.52 beats by $0.02 [3/16/2023 4:43 PM]	4.57	-0.42 (-8.42%)	4.89	-0.10 (-2.00%)	2.36 - 7.48	238,252	170,000	1,416
ORIC Pharmaceuticals GAAP EPS of -$0.52 beats by $0.02 [3/16/2023 4:43 PM]
07-11-2022	AH		ORIC	Oric Pharmaceuticals	99.00	-0.63	-0.55	0.00	ORIC Pharmaceuticals GAAP EPS of -$0.63 misses by $0.07 [11/7/2022 5:04 PM]	2.56	0.12 (4.92%)	0.0	0.0 (0.00%)	2.36 - 18.58	139,573	50,000	0
ORIC Pharmaceuticals GAAP EPS of -$0.63 misses by $0.07 [11/7/2022 5:04 PM] ORIC Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Update [Nov-07-22 04:05PM]
11-08-2022	AH	4:05 PM ET (Aug 11)	ORIC	Oric Pharmaceuticals	193.00	-0.51	-0.60	0.00	ORIC Pharmaceuticals GAAP EPS of -$0.51 beats by $0.09 [8/11/2022 5:50 PM]	4.87	0.24 (5.18%)	4.59	-0.04 (-0.86%)	2.62 - 26.70	62,448	220,000	2,459
ORIC Pharmaceuticals GAAP EPS of -$0.51 beats by $0.09 [8/11/2022 5:50 PM] ORIC Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update [Aug-11-22 04:05PM]
09-05-2022	AH	4:00 PM ET (May 9)	ORIC	Oric Pharmaceuticals	124.00	-0.59	-0.57	0.00	ORIC Pharmaceuticals GAAP EPS of -$0.59 misses by $0.02 [5/9/2022 5:26 PM]	2.90	0.20 (7.59%)	2.65	-0.05 (-1.85%)	2.62 - 26.70	260,491	666,203	102
ORIC Pharmaceuticals GAAP EPS of -$0.59 misses by $0.02 [5/9/2022 5:26 PM]
21-03-2022	AH	4:05 PM ET (Mar 21)	ORIC	Oric Pharmaceuticals, Inc.	267.01	-0.58	-0.61	-0.84	ORIC Pharmaceuticals GAAP EPS of -$0.58 in-line [3/21/2022 4:15 PM]	4.74	-1.94 (-29.04%)	5.15	-1.53 (-22.90%)	3.94 - 26.70	8,862,306	249,700	305
ORIC Pharmaceuticals GAAP EPS of -$0.58 in-line [3/21/2022 4:15 PM] Oric abandons lead candidate ORIC-101 for prostate cancer, solid tumors [3/21/2022 5:54 PM] ORIC sinks amid downgrades after ending cancer trial for lead asset [3/22/2022 11:54 AM] ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update [Mar-21-22 04:00PM] Why ORIC Pharmaceuticals Shares Are Plunging Today [Mar-22-22 09:26AM]
08-11-2021	AH	After the close (Nov 8)	ORIC	Oric Pharmaceuticals	628.00	-0.47	-0.58	0.00	ORIC Pharmaceuticals EPS beats by $0.11 [11/8/2021 5:04 PM]	17.50	1.43 (8.90%)	16.07	0.0 (0.00%)	11.91 - 40.81	301,990	170,000	425
ORIC Pharmaceuticals EPS beats by $0.11 [11/8/2021 5:04 PM] ORIC Pharmaceuticals Reports Third Quarter 2021 Financial Results and Operational Update [Nov-08-21 04:05PM]
10-08-2021	AH		ORIC	Oric Pharmaceuticals, Inc.	597.00	-0.57	-0.50	0.00	ORIC Pharmaceuticals EPS beats by $0.07 [8/10/2021 4:52 PM]	18.02	1.25 (7.45%)	16.75	-0.02 (-0.12%)	15.67 - 40.81	235,857	120,000	1,891
ORIC Pharmaceuticals EPS beats by $0.07 [8/10/2021 4:52 PM] ORIC Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Update [Aug-10-21 04:05PM]
06-05-2021	AH		ORIC	Oric Pharmaceuticals, Inc.	869.00	-0.45	-0.48	0.00	ORIC Pharmaceuticals EPS beats by $0.04 [5/6/2021 5:13 PM]	23.88	0.01 (0.04%)	23.88	0.0 (0.00%)	18.60 - 40.81	168,956	190,000	2,595
ORIC Pharmaceuticals EPS beats by $0.04 [5/6/2021 5:13 PM] ORIC Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Update [May-06-21 04:05PM]
23-03-2021	AH		ORIC	Oric Pharmaceuticals, Inc.	816.00	-0.84	-0.50	0.00	ORIC Pharmaceuticals EPS misses by $0.37 [3/23/2021 4:54 PM]	24.28	0.20 (0.83%)	24.08	0.0 (0.00%)	18.60 - 40.81	205,897	380,000	6,250
ORIC Pharmaceuticals EPS misses by $0.37 [3/23/2021 4:54 PM] ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update [Mar-23-21 04:05PM]